Gender bias in clinical trials of biological agents for severe asthma: A systematic review.
Asthma is one of the most common chronic diseases characterized by sex disparities. Gender bias is a well-documented issue detected in the design of published clinical trials (CTs). International guidelines encourage researchers to analyze clinical data by sex, gender, or both where appropriate. The...
Guardado en:
Autores principales: | Pablo Ciudad-Gutiérrez, Beatriz Fernández-Rubio, Ana Belén Guisado-Gil |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ee76433e3e7479a96ffa96344631b41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gender Bias in Artificial Intelligence: Severity Prediction at an Early Stage of COVID-19
por: Heewon Chung, et al.
Publicado: (2021) -
A Systematic Review of the Sex and Gender Reporting in COVID-19 Clinical Trials
por: Shirin Heidari, et al.
Publicado: (2021) -
Potential bias in ophthalmic pharmaceutical clinical trials
por: Paul Varner
Publicado: (2008) -
Sex and Gender Bias in Covid-19 Clinical Case Reports
por: Aysha E. Salter-Volz, et al.
Publicado: (2021) -
Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review
por: Votto M, et al.
Publicado: (2021)